NCT07385703 2026-02-04Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 3 Not yet recruiting752 enrolled